Low Brachial Artery Flow-Mediated Dilation Predicts Worse Prognosis in Hospitalized Patients with COVID-19
暂无分享,去创建一个
D. Francisci | F. Grignani | M. Pirro | A. Sahebkar | V. Bianconi | M. Mannarino | E. Schiaroli | Anna Gidari | E. Marini | E. Cosentini | Filippo Figorilli | Giuseppe Batori
[1] E. Ciolac,et al. Determinants of endothelial dysfunction in noncritically ill hospitalized COVID‐19 patients: A cross‐sectional study , 2021, Obesity.
[2] R. Arena,et al. Endothelial function provides early prognostic information in patients with COVID-19: A cohort study , 2021, Respiratory Medicine.
[3] F. Pène,et al. Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality , 2021, Angiogenesis.
[4] L. Wynants,et al. Improving clinical management of COVID-19: the role of prediction models , 2021, The Lancet Respiratory Medicine.
[5] T. Hobman,et al. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19 , 2020, Viruses.
[6] D. Asch,et al. Variation in US Hospital Mortality Rates for Patients Admitted With COVID-19 During the First 6 Months of the Pandemic , 2020, JAMA internal medicine.
[7] N. Le,et al. SARS-CoV-2 Mediated Endothelial Dysfunction: The Potential Role of Chronic Oxidative Stress , 2020, Frontiers in Physiology.
[8] H. Castro-Faria-Neto,et al. Systemic microvascular endothelial dysfunction and disease severity in COVID-19 patients: Evaluation by laser Doppler perfusion monitoring and cytokine/chemokine analysis , 2020, Microvascular Research.
[9] E. De Robertis,et al. Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients , 2020, Journal of Infection.
[10] Stephen M. Ratchford,et al. Vascular alterations among young adults with SARS-CoV-2 , 2020, American journal of physiology. Heart and circulatory physiology.
[11] G. Reboldi,et al. RAAS Inhibitors and Risk of Covid-19. , 2020, The New England journal of medicine.
[12] Chuanmin Tao,et al. An enlightening role for cytokine storm in coronavirus infection , 2020, Clinical Immunology.
[13] F. Ruschitzka,et al. Endothelial dysfunction in COVID-19: Current findings and therapeutic implications , 2020, Atherosclerosis.
[14] M. Banach,et al. Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stone , 2020, Metabolism.
[15] S. Jayasinghe,et al. Non-invasive assessment of endothelial dysfunction: A novel method to predict severe COVID-19? , 2020, Medical Hypotheses.
[16] M. Banach,et al. Interaction Between Coronavirus S-Protein and Human ACE2: Hints for Exploring Efficient Therapeutic Targets to Treat COVID-19 , 2020, Angiology.
[17] P. Libby,et al. COVID-19 is, in the end, an endothelial disease , 2020, European heart journal.
[18] L. Papazian,et al. Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19 , 2020, The Journal of infectious diseases.
[19] C. Weber,et al. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science , 2020, Cardiovascular research.
[20] Jordan J. Clark,et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score , 2020, BMJ.
[21] E. K. Ha,et al. Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching , 2020, Gut.
[22] F. Violi,et al. Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ? , 2020, Drugs.
[23] Michael D Healy,et al. SARS-CoV-2 viral load is associated with increased disease severity and mortality , 2020, Nature Communications.
[24] L. Margolis,et al. Dynamics of coagulopathy in patients with different COVID-19 severity , 2020, medRxiv.
[25] C. D. Dela Cruz,et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study , 2020, The Lancet Haematology.
[26] D. Yellon,et al. The cytokine storm of COVID-19: a spotlight on prevention and protection , 2020, Expert opinion on therapeutic targets.
[27] A. Zangrillo,et al. Decreased in-hospital mortality in patients with COVID-19 pneumonia , 2020, Pathogens and global health.
[28] Deepak K Nandikanti,et al. Medical Management of COVID-19: Evidence and Experience , 2020, Journal of clinical medicine research.
[29] P. Carmeliet,et al. COVID-19: the vasculature unleashed , 2020, Nature Reviews Immunology.
[30] D. Kelvin,et al. COVID-19 as a cardiovascular disease: the potential role of chronic endothelial dysfunction , 2020, Cardiovascular research.
[31] P. Salari,et al. COVID-19 and off label use of drugs: an ethical viewpoint , 2020, DARU Journal of Pharmaceutical Sciences.
[32] Holger Moch,et al. Endothelial cell infection and endotheliitis in COVID-19 , 2020, The Lancet.
[33] Dong Wei,et al. Clinical Features Predicting Mortality Risk in Patients With Viral Pneumonia: The MuLBSTA Score , 2019, Front. Microbiol..
[34] C. Oury,et al. A Review of the Role of Bradykinin and Nitric Oxide in the Cardioprotective Action of Angiotensin-Converting Enzyme Inhibitors: Focus on Perindopril , 2019, Cardiology and therapy.
[35] Tsung-Ming Lee,et al. Blockade of Cardiac Proton Pump Impairs Ventricular Remodeling Through a Superoxide-DDAH-Dependent Pathway in Infarcted Rats. , 2019, Acta Cardiologica Sinica.
[36] E. Mannarino,et al. Urinary albumin-to-creatinine ratio is associated with endothelial dysfunction in HIV-infected patients receiving antiretroviral therapy , 2016, Scientific Reports.
[37] W. Gasper,et al. Ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery in clinical research. , 2014, Journal of visualized experiments : JoVE.
[38] E. Mannarino,et al. Age-Specific Relationship of Aortic Pulse Wave Velocity With Left Ventricular Geometry and Function in Hypertension , 2007, Hypertension.
[39] T. Heeren,et al. Endothelial function in HIV-infected persons. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[40] E. Mannarino,et al. Acute inflammatory state during influenza infection and endothelial function. , 2005, Atherosclerosis.
[41] E. Mannarino,et al. Paraoxonase-1 activity modulates endothelial function in patients with peripheral arterial disease. , 2005, Atherosclerosis.
[42] A. Morelli,et al. Nitric Oxide Regulates Immune Cell Bioenergetic: A Mechanism to Understand Immunomodulatory Functions of Nitric Oxide-Releasing Anti-Inflammatory Drugs , 2004, The Journal of Immunology.
[43] P. Maes,et al. Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound☆ , 2004, International Journal of Infectious Diseases.